Cargando…
Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review
INTRODUCTION: Metformin is a first-line drug choice for the treatment of type 2 diabetes mellitus (DM-2). Metformin-induced hepatotoxicity has rarely been reported. We report on a case of metformin-induced mixed hepatocellular and cholestatic liver injury in an elderly patient with DM-2 as well as r...
Autores principales: | Saadi, Tarek, Waterman, Matti, Yassin, Heba, Baruch, Yaacov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751382/ https://www.ncbi.nlm.nih.gov/pubmed/23983487 http://dx.doi.org/10.2147/IJGM.S49657 |
Ejemplares similares
-
Case Report: Mixed Cholestatic/Hepatocellular Liver Injury Induced by the Herbicide Quizalofop-p-ethyl
por: Elefsiniotis, Ioannis S., et al.
Publicado: (2007) -
Mechanisms of Hepatic Cholestatic Drug Injury
por: Kolarić, Tea Omanović, et al.
Publicado: (2019) -
Methimazole-induced cholestatic hepatitis: two cases report and literature review
por: Zou, Hai, et al.
Publicado: (2015) -
Kratom-Associated Mixed Cholestatic-Hepatocellular Liver Injury in a Patient With Long COVID: A case Report
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022) -
Azathioprine induced cholestatic hepatitis
por: Moses, Viju, et al.
Publicado: (2011)